A variety of different signals induce specific responses through a common, ERK-dependent kinase cascade. It has been suggested that signaling specificity can be achieved through precise temporal regulation of ERK activity. Given the wide distrubtion of ERK susbtrates across different subcellular compartments, it is important to understand how ERK activity is temporally regulated at specific subcellular locations. To address this question, we have expanded the toolbox of FRET-based ERK biosensors by creating a series of improved biosensors targeted to various subcellular regions via sequence specific motifs to measure spatiotemporal changes in ERK enzymatic activity. Using these sensors, we showed that EGF induces sustained ERK activity near the plasma membrane in sharp contrast to the transient activity observed in the cytopolasm and nucleus. Furthermore, EGF-induced plasma membrane ERK activity involves Rap1, a noncanonical activator, and controls cell morphology and EGF-induced membrane protrusion dynamics. Our work strongly supports that spatial and temporal regulation of ERK activity is integrated to control signaling specificity from a single extracellular signal to multiple cellular processes.
Introduction
Due to its central role in signal transduction, Extracellular-signal regulated kinase (ERK) has been the subject of intense study for over three decades (1, 2) ; this research has elucidated many of the key mechanisms of ERK regulation. This pathway is utilized by a host of different extracellular cues to regulate cellular processes such as proliferation, differentiation, and survival (3, 4) . However, studies have shown that ERK is also critically involved in regulating many other cellular processes, such as cell migration (5, 6) , cell cycle progression (7, 8) , autophagy (9,10), metabolism (11, 12) , insulin secretion (13), or even apoptosis (14, 15) . The variety of processes induced through the ERK pathway presents a conundrum: how do extracellular cues specifically regulate the ERK pathway to induce the proper cellular response?
The canonical mode of regulation is activation by phosphorylation at the end of a kinase cascade.
ERK is phosphorylated by the protein kinase MEK, which is first activated by the protein kinase Raf. Raf kinases are activated through the GTPase Ras, which is activated downstream of extracellular signals such as Epidermal Growth Factor (EGF) (4, 16) . However, because ERK is activated by phosphorylation by a host of divergent extracellular signals, more complex modes of regulation must exist in order to direct ERK activity towards appropriate responses.
Previous studies have shown that different extracellular signals induce distinct temporal patterns of ERK activation to encode specific signaling information (17) (18) (19) . For example, in model cell lines such as PC12 or MCF7, Epidermal Growth Factor (EGF) treatment leads to transient ERK phosphorylation and cell proliferation whereas alternate extracellular signals such as Nerve Growth Factor (NGF) or heregulin, respectively, induces a sustained ERK phosphorylation and cell differentiation. In the case of PC12 cells, the latter includes neurite formation and an enlarged cell body, modeling differentiated neurons. However, previous studies primarily used immunoblotting techniques to monitor ERK activation dynamics. While this technique has yielded crucial information, it is ultimately limited in its spatiotemporal resolution and unable to resolve single cell behavior or differential dynamics between subcellular compartments. ERK substrates have been identified in many subcellular compartments including at the Golgi Apparatus (20) (21) (22) , at the mitochondrial membrane (23, 24) , and near the plasma membrane (5, 6) .
However, studies investigating the spatial regulation of ERK have primarily focused on understanding its activation and role in shuttling between the nucleus and cytoplasm, leaving the regulation and function of ERK in other subcellular compartments relatively unexplored. We hypothesize that spatial compartmentalization of ERK activity is required for signaling specificity in order for signals such as EGF to regulate different functional responses via distinct compartmentalized ERK activation. To test our hypothesis, we utilized genetically encoded molecular tools to visualize and perturb the activities of specific subcellular pools of endogenous ERK. Using this native biochemistry approach, we discovered that ERK activity associated with the plasma membrane exhibits distinct temporal dynamics in contrast to cytoplasmic and nuclear pools of ERK. We further dissected the mechanism of this distinct regulation and discovered that plasma membrane ERK activation is required for regulating Rac1 and controlling actin protrusion dynamics.
Results

EGF-induced ERK is activated transiently in the cytoplasm but sustained near the plasma membrane.
While previous studies revealed that the temporal dynamics of ERK activation play a pivotal role in promoting specific cellular responses to extracellular stimuli (17, 18, 25) , studies on the spatial activation of ERK in signal transduction has been mostly focused on its translocation to the nucleus despite the fact that ERK has hundreds of substrates in other subcellular compartments (26) . For example, ERK has several known substrates near the plasma membrane, including Focal Adhesion Kinase (27) and the actin-effector WASP (6). Thus, we sought to determine whether a single extracellular signal could induce different activity dynamics of spatially distinct pools of ERK to promote functional cellular processes. To address this question, we developed a new toolset of genetically-encoded, spatially-localized fluorescent biosensors based on the ERK Kinase Activity Reporter (EKAR) (25, 28) , an engineered fluorescent ERK substrate that will exhibit different FRET properties in response to phosphorylation by ERK. These biosensors consist of two fluorescent proteins flanking a WW phosphopeptide-binding domain, a linker region, and an ERK-specific substrate domain ( Figure 1A ). Upon phosphorylation of the substrate sequence by ERK, the WW phosphopeptide-binding domain interacts with the phosphorylated substrate sequence, bringing the two fluorescent proteins into close proximity, thereby increasing FRET (29). Thus, by expressing the biosensor within cells, one can monitor ERK activity in living cells in real-time by exciting the donor fluorescent protein and measuring the changes in the ratio of acceptor to donor fluorescence, yellow over cyan (Y/C), which is often reported as a percent increase over basal signal. Previous versions of EKAR include EKAR2G, and EKAR3 (28, 30, 31) . While each of these biosensors has improved upon past biosensors, each of their reported average response to EGF is below 50%, which limits their utility to be used when targeted to specific subcellular locations. In seeking to develop a new EKAR biosensor with sufficient dynamic range in order to maximize signal when the biosensor is restrained to specific locations, we found that switching the positions of the fluorescent proteins within the EKAR-EV biosensor such that Ypet was positioned C-terminally and ECFP was positioned N-terminally ( Figure 1A ) yielded a biosensor that generated an 74.5 ± 2.3% increase in the Y/C emission ratio (n = 83) ( Figure 1 Supplement 1B,C). We reasoned that this enhanced EKAR, which we have termed EKAR4, can then be targeted to specific subcellular locations, such as the cytoplasm, plasma membrane, or nucleus, to enable reliable tracking of ERK temporal dynamics in these specific locations. Thus, we used a Nuclear export sequence (NES) to create a cytosolic targeted EKAR4 (EKAR4-NES), a nuclear localization sequence (NLS) to create a nuclear targeted EKAR4 (EKAR4-NLS), and the hypervariable region of KRas including a polylysine and CAAX box sequence to create a plasma membrane-localized EKAR4 (pmEKAR4), each of which displayed correct localization (32) ( Figure 1B EGF-stimulated pmEKAR4 response was much more sustained at the plasma membrane ( Figure   1D ), compared to cytosol and nucleus. We developed a metric to quantitate the relative temporal dynamics between conditions (Equation 1), which we refer to as Sustained Activity Metric at 40 minutes post-treatment (SAM40), where R represents the normalized emission ratio at the indicated condition in subscript. An advantage of this metric is that it presents the residual signal at 40 minutes from the maximum signal after treatment. Using this metric, we were able to determine that EKAR4 response at the plasma membrane was indeed statistically different from the cytoplasmic and nuclear ERK responses ( Figure 1E Interestingly, we also found that the time to full activation was slower at the plasma membrane than cytosolic or nuclear activation ( Figure 1 
To test if the sustained response at the plasma membrane requires continuously active ERK at the plasma membrane, we treated the cells with a membrane permeable ERK inhibitor SCH772984 (33) and examined the EKAR4 responses. We found that addition of 10 µM SCH772984, but not of DMSO, either at 10 minutes after EGF stimulation (blue curve) or at 40 minutes post-stimulation (orange curve) led to an immediate decrease in EKAR4 signal, indicating that ERK was still actively phosphorylating EKAR4 at these time points (Figure 2A ,
To further validate the activation of ERK at different subcellular compartments, we performed biochemical subcellular fractionation to separate and quantitate ERK phosphorylation at the plasma membrane and cytoplasm of PC12 cells to assess the temporal dynamics of phosphorylated ERK. ERK was phosphorylated transiently in the cytoplasm and ERK associated with the plasma membrane was equally, on average, phosphorylated between the 15-and 40minute time points ( Figure 2B , quantitated from five independent replicates in C), indicating the presence of a continuously phosphorylated pool of ERK at the plasma membrane. In conclusion, these data indicate that ERK activity associated with the membrane is sustained in contrast to the transient response in the cytoplasm and nucleus, and thus differentially regulated between these subcellular compartments.
Rap1 GTPase significantly contributes to plasma membrane ERK activity
The unique temporal pattern of ERK activity at the plasma membrane prompted us to determine whether plasma membrane ERK activity is distinctly regulated. The classical pathway of ERK activation is through the Ras family of GTPases, including K-ras, H-ras, and N-Ras. However, it has been shown that Rap1, a GTPase in the Ras family, can in some cases specifically interact with B-Raf and lead to sustained ERK activity under certain conditions (34) (35) (36) between Rap1 and RBD, thereby increasing FRET. Using these biosensors in PC12 cells, we observed that EGF consistently induced increases in Y/C emission ratios, indicating activation of both Rap1A (25.4% ± 4.7%, n=11) and Rap1B (26% ± 3.4%, n=8); this effect was completely abrogated by co-expression of the Rap1-specific GTPase-activating protein Rap1GAP, which selectively inactivates Rap1 by inducing the hydrolysis of the bound GTP to GDP ( Figure 3A , B, red curves) (40, 41) . We also tested Rap1 activation near the plasma membrane by using Total
Internal Reflection Microscopy (TIRF) to monitor the translocation to the plasma membrane of a FP-tagged effector molecule that binds to GTP bound form of Rap1. For this assay, we utilized the RBD from diffusible, FP-tagged RalGDS (37). We also co-expressed a membrane-targeted variant of RFP, mCherry, in PC12 cells in order to aid in finding cells in TIRF microscopy and to control for changes in fluorescence intensity due to cell spreading and/or movement. In these cells, EGF induced an average maximum response of 64.8% ± 11% (n=11) increase in ratio of EGFP to mCherry at the basal membrane, while control cells expressing EGFP showed no changes in EGFP fluorescence intensity at the membrane ( Figure 3 -Supplement 1).
Furthermore, co-expression of Rap1GAP abolished the translocation of the RBD, further confirming the specificity of the response.
Having verified EGF induces Rap1 activation near the plasma membrane, we investigated how abrogation of Rap1 would affect plasma membrane localized ERK activity. We used two different approaches to inhibit Rap1. First, Rap1GAP inhibition of both Rap1A and Rap1B led to a dramatic dampening of EGF-induced ERK activity near the plasma membrane ( Figure 3C , E).
However, Rap1GAP had no effect on cytosolic ERK activity ( . These data indicate that Rap1 is critically involved in regulating plasma membrane ERK activity. This mechanism is notably different from the canonical Rasmediated activation of ERK, which appears to regulate the cytoplasmic and nuclear ERK activities.
Plasma membrane ERK activity regulates cellular morphology and EGF-induced protrusion dynamics
After identifying a distinct pool of ERK with different temporal dynamics and pathway of activation than cytosolic or nuclear pools of ERK, we sought to identify the function of this pool of ERK near the membrane. We utilized an ERK monobody binder (EMBer) (43) that interacts with ERK and inhibits its activity but does not interact with JNK or p38, kinases from the same family as ERK. Using plasma membrane targeted EMBer tagged with mCherry (pmEMBer), we observed a significantly reduced ERK activity near the plasma membrane ( Figure 4A ) but not in the cytosol ( Figure 4B ) or nucleus (Figure 4 Supplement 1A). Thus, plasma membrane targeted EMBer could indeed be used to selectively inhibit the plasma membrane ERK activity. In cells expressing pmEMBer, we first observed an apparent change in cell morphology from primarily circular to primarily elliptical ( Figure 4C ). We quantified this morphological change by measuring the ratio of the minor to major axes of each cell, comparing between pmEMBer expressing cells and non-pmEMBer expressing cells ( Figure 4D , Left panel). In cells without pmEMBer, 58% of imaged cells have a minor:major axes ratio greater than 0.8, indicating that the majority of cells were nearly perfectly round. Only ~8% of cells without pmEMBer had a ratio below 0.6. In contrast, 42% of pmEMBer expressing cells had a ratio below 0.6. This drastic change in cell morphology, which is dependent on pmEMBer expression at the plasma membrane, indicates that ERK activity near the membrane has an important role in controlling cell morphology.
In conjunction with the observed changes in morphology, we observed apparent changes in EGFinduced membrane protrusion dynamics. To quantitate these observations, we co-expressed either pmEMBer or plasma membrane targeted mCherry with LifeAct-Venus (44) to visualize actin dynamics. In each of these conditions, cells were treated with EGF and imaged every 30 seconds for up to 45 minutes after stimulation. To quantitate the differences in protrusion dynamics, lines were drawn across the major axis of each cell and a kymograph was generated to quantitate the spatial and temporal aspects of protrusion dynamics (Figure 4 -Supplement 2).
Under control conditions, EGF induced relatively short-lived, evenly distributed small protrusions ( Figure 4D , middle, right panels). However, under conditions of selective plasma membrane inhibition of ERK activity near the plasma membrane, cells exhibited longer and polarized protrusion dynamics ( Figure 4D , middle, right panels). Specifically, in normal conditions, 28% of cells had protrusions longer than 5 µm and the protrusions of 25% of these cells lasted for longer than 15 minutes. In contrast, in pmERK-inhibited conditions, 70% of cells had protrusions longer than 5 µm and 75% of pmERK-inhibited cells had protrusions lasting longer than 15 minutes.
As described earlier, there are known ERK substrates near the membrane that could have the observed effect on cell morphology and protrusions, such as WASP, FAK, among others (45).
Furthermore, it is well established that the Rho family of GTPases, Rac1 and RhoA, are significant players in cell protrusion and migration processes. Importantly, Rac1 is a known substrate for ERK, and EGF-induced Rac1 phosphorylation by ERK in COS-7 cells was shown to lead to inhibition of Rac1 and its removal from the plasma membrane (46). Thus, we sought to examine how inhibition of pmERK affected Rac1 and RhoA activity in PC12 cells.
In order to monitor Rac1 and RhoA activation, we took advantage of established single-chain Rac1 and RhoA biosensors: Rac1-2G (47) and RhoA-DORA(48). Rac1-2G consists of mTFP (variant of CFP) on the N-terminus, a circularly permutated variant of Venus, with the PAK effector binding domain in between the two fluorescent proteins and a full length Rac1 at the Cterminal end; upon Rac1 binding with GTP, the PAK effector domain will interact with Rac1-GTP, bringing the two fluorescent proteins into close proximity to increase FRET. The RhoA biosensor has a similar design, with a circularly permutated Rho-binding domain of PKN1 on the N-terminus, followed by cpVenus, a linker region, Cerulean, and then full-length RhoA. We expressed either of these biosensors in cells along with either plasma membrane targeted mCherry (control) or pmEMBer. Although we could not observe RhoA activity under either condition ( Figure 4 -Supplement 3C, D, E), using Rac1-2G we did observe a robust 6.4% ± 0.7% increase in response to EGF (n=19, control; n=24, with pmEMBer) under pmERKinhibited conditions but not under control conditions ( Figure 4E , F), indicating endogenous pmERK inhibits Rac1 activation. This observation is consistent with previous reports in which ERK phosphorylation of Rac1 on T108 inhibits Rac1 and leads to relocalization of Rac1 away from the membrane (46) and indicates that plasma membrane ERK activity inhibits Rac1, which could contribute to the regulation of membrane protrusion dynamics.
Discussion
Although ERK is ubiquitously utilized by a host of different cellular processes, the majority of studies on ERK focus on its primary role in proliferation and survival. Previous studies often focus on investigating the extent of ERK phosphorylation and its effect on transcription factors in the nucleus. However, ERK is known to have hundreds of substrates localized in different subcellular compartments and play key roles in differentiation, migration, and others (4,45,49).
Despite our knowledge of substrate localization, little is known about the regulation of ERK in specific subcellular compartments outside of the nucleus. This is largely due to the traditional method of using phospho-specific antibodies on whole lysates, which are equated, perhaps erroneously (50,51), with full activity, and may mask subpopulations of ERK amidst the majority population. While we know that temporal dynamics plays a major role in determining cellular processes resulting from an extracellular cue, we have not been unable to critically assess whether an individual extracellular signal can induce distinct temporal dynamics among two or more different subcellular compartments.
In this study, we established the use of fluorescent, FRET-based biosensors to study the spatiotemporal dynamics of ERK activity by targeting the biosensors to specific subcellular regions, particularly the plasma membrane, cytosol, and nucleus. Using this technique, we discovered that EGF simultaneously activates at least three divergent sub-populations of ERK with unique temporal dynamics from each other: the cytosol ( Figure 1C ), the Plasma membrane ( Figure 1D ), and the nucleus (Figure 1-Supplement 1C ). Indeed, we found that ERK activation in the nucleus was transient, slightly more sustained in the cytoplasm (Figure 1 -supplement 1D) and drastically more sustained near the plasma membrane ( Figure 1D , E). Furthermore, by using a membrane permeable ERK inhibitor, we confirmed that the sustained pmEKAR4 signal was a direct result of continued ERK phosphorylation of the biosensor and not because the biosensor was unable to be dephosphorylated by a lack of phosphatases near the membrane (Figure 2A ). Additionally, subcellular fractionation was able to confirm the presence of sustained ERK phosphorylation in the plasma membrane fraction ( Figure 2B , C).
To delineate into the mechanism by which ERK activity at the membrane is activated, we examined the upstream GTPase responsible for ERK activation and discovered a noncanonical Rap1-mediated pathway. Past studies have linked Rap1 to ERK signaling because Rap1 is able to interact with and activate B-Raf (34). However, this point has been controversial and it is not clear whether or not Rap1 actually activates ERK in a cellular environment, with studies giving disparate reports on whether EGF induces Rap1 activation in PC12 cells (37,52-56). These contradicting observations are likely due to the fact that the traditional biochemical method for measuring enzyme activation may not capture transient or specific subcellularly-localized activation (37). In this study, with the use of recently reported Rap1 biosensors (39) and our livecell TIRF-based EGFP-RalGDS translocation assay, we were able to show that, in PC12 cells, EGF does indeed activate Rap1 at the plasma membrane. Using Rap1GAP and a dominant negative form of Rap1B, combined with our plasma membrane ERK activity reporter, we further showed that Rap1 is critically involved in regulating plasma membrane ERK activity but does not appear to contribute to cytosolic or nuclear ERK activities. Future studies will test the involvement of B-Raf in Rap1-mediated plasma membrane ERK activation.
Furthermore, our study provides a striking example where an individual extracellular signal, such as EGF, can temporally regulate subcellular ERK populations to control distinct cellular processes. We showed that inhibition of membrane-localized ERK activity potentiates EGFinduced Rac1 activation and leads to enhanced membrane protrusion dynamics. These data suggest that EGF, in addition to inducing cell proliferation, also stimulates plasma membrane ERK activity to suppress Rac1 activity to prevent unwanted membrane protrusions and polarization. The latter effect likely requires the sustained ERK activity at the plasma membrane.
It is tempting to speculate that the ERK-suppressed morphology and protrusions are related to PC12 cell differentiation, due to the qualitative resemblance of shape and protrusion dynamics for pmEMBer-expressing cells compared to cells shortly after NGF treatment (57). Thus, spatial and temporal dynamics are intricately linked to encode specific signaling information and regulate distinct cellular processes that result from individual extracellular signals such as EGF.
With the genetically targeted molecular tools for both visualization and manipulation of specific signaling events, our work also lays the foundation to enable future studies to further elucidate the mechanisms of regulation and functional roles of distinct subcellular populations of ERK.
Methods
Reagents. ERK inhibitor SCH772984 was obtained from Sellek chemicals. ERK1/2 (Cell Signaling Technology Cat# 9102, RRID:AB_330744) and phospho-ERK1/2 (Cell Signaling Technology Cat# 9101, RRID:AB_331646) antibodies were from CST. Epidermal growth factor (EGF) was from Sigma-Aldrich.
Plasmid generation and molecular biology. EKAR-EV was kindly provided by Michiyuki
Matsuda. To generate EKAR4, locations of ECFP and Ypet were swapped by restriction digest.
Subcellular targeting sequences were subcloned onto the C-terminal end of EKAR4 in between the EcoRI and XbaI restriction sites. The sequences include: for nuclear export sequence (5'-GAATTCCTGCCCCCCCTGGAGCGCCTGACCCTGTAA-3'), for nuclear import sequence All filter sets were alternated by a Lambda 10-2 filter-changer (Sutter Instruments). Exposure times ranged between 50 and 500ms, with the EM gain set from 10 to 50, and images were the ratio at 40 minutes post-EGF treatment, R 0 is the point preceding EGF stimulation, and R max is the maximum ratio value recorded after stimulation. Graphs were plotted using GraphPad Prism 7 (GraphPad Software).
Morphology and protrusion analysis. Morphology was measured using ImageJ software to measure the distance, in microns, of the major and minor axes of each cell, and the ratio of the minor:major axes was compared between cells with versus without pmEMBer expression.
Protrusion dynamics was measured using ImageJ software by creating a line across the major axis of each cell, and subsequently creating a kymograph from the stack of time course images.
For the kymograph, the x-axis indicated distance (microns) and the y-axis indicated time (30s per pixel). Using the kymographs, length in distance and time of each protrusion was measured and compared between conditions (Figure 4 -Supplement 2) . This analysis was done to remove cells from analysis in which extremely high or low expression of the biosensor affected cell behavior; cells were cut from each condition until Pearson's correlation coefficient was below 0.5.
Total internal reflection microscopy (TIRF
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